About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Magnetoencephalography (MEG) Pilot Study | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT07446192

Magnetoencephalography (MEG) Pilot Study

The purpose of this research is to learn more about how the brain works in people with essential tremor, and how it changes after treatment with High-Intensity Focused Ultrasound (HiFU). Essential tre...

Lead sponsor: University of Florida•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

subeikshanan venkatesan, MBBS

CONTACT

352-273-9000 subeikshanan.venkatesan@neurology.ufl.edu

Sponsors

Lead Sponsor

University of Florida

Participation in this study will last for approximately eight months. Participants will be asked to attend a total of six study visits. These include a screening visit to see if a potential participant qualifies for the study, an assessment visit before treatment and treatment visits. Prior to and after treatment (one day, six weeks, and six months after treatment), participants will have Magnetoencephalography (MEG), Functional Magnetic Resonance Imaging (fMRI), Sensor-Based Gait and Motor Function Assessments and Self-Report Questionnaires.

Age

50 - 84 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Inclusion:
•Age \>50 years and \<85 years
•Refractory to at least 2 first line tremor medications
•Skull Density Ratio (SDR) \> = 0.35
•Exclusion:
•MR/MEG incompatible implants and implantable devices (ex: pacemaker)
•Head tremor interfering with MEG recording
•Severe depression and/or anxiety
•Severe cognitive impairment

Related studies

RECRUITINGPhase 1

Coordinated Reset Deep Brain Stimulation for Essential Tremor

NCT05897775 · Essential Tremor, Upper Extremity Essential Tremor

EMBRACE Tremor BiFUS

NCT06974916 · Essential Tremor

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT06553625 · Parkinson Disease, Dystonia, and more

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

NCT07428447 · Essential Tremor, Movement Disorders, Essential Tremor, and more

LIFUS For Neurological Disorders

NCT07417280 · Parkinson's Disease (PD), Essential Tremor, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 1, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment10

Start dateFeb 2026

Last updatedMay 1, 2026

Condition

Essential Tremor

Locations shown

UF Health

Gainesville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions